| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R7H7 | B-cell novel protein 1, isoform CRA_b; | BCNP1; | NULL | 433 | human |
| A8MY26 | Down syndrome critical region protein 3; cDNA FLJ53689, highly similar to Down syndrome critical region protein 3; | DSCR3; | XP_005260968.1; | 172 | human |
| M4NBK9 | KIR2DL3; Fragment; | NULL | NULL | 273 | human |
| Q9UFS0 | ANKRD25 protein; Putative uncharacterized protein DKFZp434N161; | DKFZp434N161; ANKRD25; | NULL | 99 | human |
| F5H215 | Protein FAM76B; Fragment; | FAM76B; | NULL | 91 | human |
| Q4VB54 | Nuclear transition protein 2; | TNP2; | NULL | 138 | human |
| F2Z310 | 28S ribosomal protein S24, mitochondrial; | MRPS24; | NULL | 29 | human |
| A0A024R3Z4 | Zinc finger protein, subfamily 1A, 2 (Helios), isoform CRA_c; | ZNFN1A2; | NULL | 473 | human |
| Q8HBV1 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| A0A023R2W4 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| G8CWL5 | Glycophorin B; Fragment; | GYPB; | NULL | 45 | human |
| A0A024R5S0 | HCG2003792, isoform CRA_a; | NULL | NULL | 98 | human |
| Q53QD2 | Putative uncharacterized protein UGT1; UDP-glucuronosyltransferase 1A4; Fragment; | UGT1; UGT1A4; | NULL | 289 | human |
| B4DW45 | CD19 antigen, isoform CRA_f; cDNA FLJ60916, highly similar to B-lymphocyte antigen CD19; | CD19; | NULL | 159 | human |
| A0A059RP89 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| Q6RRV0 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| G5E9H6 | Dapper homolog 3; Thymus expressed gene 3-like, isoform CRA_b; | DACT3; MGC15476; | NULL | 181 | human |
| J7HHH7 | Retinoic acid early transcript 1H; Retinoic acid early transcript 1L; Fragment; | RAET1L; RAET1H; | NULL | 87 | human |
| D1GI28 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| Q9HB66 | Alternative protein MKKS; McKusick-Kaufman syndrome, isoform CRA_a; McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin; PNAS-117; | MKKS; | NULL | 63 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |